Heron Therapeutics, Inc. (0J4V.L)

USD 1.62

(0.31%)

Eps Summary of Heron Therapeutics, Inc.

  • Heron Therapeutics, Inc.'s latest annual eps in 2023 was -0.80 USD , up 52.1% from previous year.
  • Heron Therapeutics, Inc.'s latest quarterly eps in 2024 Q2 was -0.06 USD , down -189.95% from previous quarter.
  • Heron Therapeutics, Inc. reported an annual eps of -1.67 USD in 2022, up 25.45% from previous year.
  • Heron Therapeutics, Inc. reported an annual eps of -2.24 USD in 2021, up 10.4% from previous year.
  • Heron Therapeutics, Inc. reported a quarterly eps of -0.06 USD for 2024 Q2, down -189.95% from previous quarter.
  • Heron Therapeutics, Inc. reported a quarterly eps of -0.27 USD for 2023 Q1, down -58.82% from previous quarter.

Annual Eps Chart of Heron Therapeutics, Inc. (2023 - 2012)

Historical Annual Eps of Heron Therapeutics, Inc. (2023 - 2012)

Year Eps Eps Growth
2023 -0.80 USD 52.1%
2022 -1.67 USD 25.45%
2021 -2.24 USD 10.4%
2020 -2.50 USD 0.0%
2019 -2.50 USD -2.46%
2018 -2.44 USD 33.15%
2017 -3.65 USD 20.13%
2016 -4.57 USD -54.92%
2015 -2.95 USD -2.79%
2014 -2.87 USD 16.08%
2013 -3.42 USD -71.0%
2012 -2.00 USD 0.0%

Peer Eps Comparison of Heron Therapeutics, Inc.

Name Eps Eps Difference
Editas Medicine, Inc. -2.02 USD 60.396%
Dynavax Technologies Corporation -0.05 USD -1512.903%
Supernus Pharmaceuticals, Inc. 0.02 USD 3419.502%
Perrigo Company plc -0.09 USD -751.97%
Illumina, Inc. -7.35 USD 89.116%
Thermo Fisher Scientific Inc. 15.53 USD 105.151%
Iovance Biotherapeutics, Inc. -1.89 USD 57.672%
Walgreens Boots Alliance, Inc. -10.01 USD 92.008%
IQVIA Holdings Inc. 7.39 USD 110.825%
Regeneron Pharmaceuticals, Inc. 37.05 USD 102.159%
Unity Biotechnology, Inc. -2.70 USD 70.37%
Waters Corporation 10.87 USD 107.36%
Biogen Inc. 8.02 USD 109.975%
Sangamo Therapeutics, Inc. -1.48 USD 45.946%
Evolus, Inc. -1.08 USD 25.926%
Adicet Bio, Inc. -3.31 USD 75.831%
Cara Therapeutics, Inc. -2.19 USD 63.47%
bluebird bio, Inc. -1.93 USD 58.549%
Esperion Therapeutics, Inc. -2.03 USD 60.591%
FibroGen, Inc. -2.92 USD 72.603%
Agilent Technologies, Inc. 4.22 USD 118.957%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 92.241%
Homology Medicines, Inc. -7.41 USD 89.204%
Geron Corporation -0.32 USD -150.0%
Alnylam Pharmaceuticals, Inc. -3.52 USD 77.273%
Amicus Therapeutics, Inc. -0.51 USD -56.863%
Myriad Genetics, Inc. -1.39 USD 42.446%
Viking Therapeutics, Inc. -0.91 USD 12.088%
Intellia Therapeutics, Inc. -5.42 USD 85.24%
Zoetis Inc. 5.08 USD 115.748%
Abeona Therapeutics Inc. -2.53 USD 68.379%
Mettler-Toledo International Inc. 36.10 USD 102.216%
BioMarin Pharmaceutical Inc. 0.89 USD 189.888%
Vertex Pharmaceuticals Incorporated 14.05 USD 105.694%
Kala Pharmaceuticals, Inc. -17.35 USD 95.389%
Ionis Pharmaceuticals, Inc. -2.56 USD 68.75%
Atara Biotherapeutics, Inc. -65.18 USD 98.773%
Verastem, Inc. -3.96 USD 79.798%
Nektar Therapeutics -1.45 USD 44.828%
Axsome Therapeutics, Inc. -5.27 USD 84.82%
Aclaris Therapeutics, Inc. -1.27 USD 37.008%
Sarepta Therapeutics, Inc. -5.80 USD 86.207%
OPKO Health, Inc. -0.25 USD -220.0%
Exelixis, Inc. 0.65 USD 223.077%
Neurocrine Biosciences, Inc. 2.56 USD 131.25%
Corcept Therapeutics Incorporated 1.02 USD 178.431%
Anavex Life Sciences Corp. -0.60 USD -33.333%
uniQure N.V. -6.47 USD 87.635%
Imunon, Inc. -2.16 USD 62.963%
Blueprint Medicines Corporation -8.37 USD 90.442%
Insmed Incorporated -5.34 USD 85.019%
Halozyme Therapeutics, Inc. 2.13 USD 137.559%
Agios Pharmaceuticals, Inc. -6.33 USD 87.362%
TG Therapeutics, Inc. 0.09 USD 995.857%
Incyte Corporation 2.67 USD 129.963%
Emergent BioSolutions Inc. -14.85 USD 94.613%